Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT00203034
Brief Summary:
Study for patients currently using Levodopa/Carbidopa who will be assigned to receive either Rasagiline or Placebo
Study:
NCT00203034
Study Brief:
Protocol Section:
NCT00203034